Keywords: Clinical practice; Metastatic RCC; Registry; TKI; Treatment patterns;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: kidney; carcinoma; renal cell; neoplasm metastasis; interleukin-2; molecular targeted therapy; CR; complete response; ECOG; Eastern Cooperative Oncology Group; HDIL-2; high dose IL-2; IL-2; interleukin-2; mRCC; metastatic RCC; OS; overall survival; PD; pr
Comparative Survival following Initial Cytoreductive Nephrectomy versus Initial Targeted Therapy for Metastatic Renal Cell Carcinoma
Keywords: kidney neoplasms; carcinoma; renal cell; neoplasm metastasis; nephrectomy; mortality; CN; cytoreductive nephrectomy; IPTW; inverse probability of treatment weighting; mRCC; metastatic RCC; NCDB; National Cancer Database; OS; overall survival; RCC; renal c
Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor Thrombus
Keywords: carcinoma; renal cell; neoplasm metastasis; thrombosis; vena cava; inferior; mortality; CN; cytoreductive nephrectomy; IMDC; International Metastatic Renal-Cell Carcinoma Database Consortium; IVC; inferior vena cava; MDACC; M. D. Anderson Cancer Center; m
Temporal Trends and Factors Associated with Systemic Therapy after Cytoreductive Nephrectomy: An Analysis of the National Cancer Database
Keywords: kidney; carcinoma; renal cell; nephrectomy; neoplasm metastasis; physician's practice patterns; CN; cytoreductive nephrectomy; mRCC; metastatic RCC; NCDB; National Cancer Data Base; RCC; renal cell carcinoma;
Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study
Keywords: Metastatic RCC; Everolimus; mTOR inhibitor; VEGFr-TKI; Progression-free survival; Sequential therapy
Health-related quality of life in patients with advanced renal cell carcinoma receiving pazopanib or placebo in a randomised phase III trial
Keywords: Renal cell carcinoma; Metastatic RCC; Pazopanib; Health-related quality of life;
Mechanism of Synergistic Antitumor Effect of Sorafenib and Interferon-α on Treatment of Renal Cell Carcinoma
Keywords: kidney; carcinoma; renal cell; sorafenib; interferon-alpha; antineoplastic combined chemotherapy protocols; CI; combination index; CTL; cytotoxic T lymphocyte; DC; dendritic cell; Fa; fraction affected; HLBI; human lymphoblastoid IFN-α; IC; inhibitory co